Literature DB >> 20691050

Fatal cold agglutinin-induced haemolytic anaemia: a case report.

Gianluca Lodi1, Daniela Resca, Roberto Reverberi.   

Abstract

INTRODUCTION: Cold agglutinin disease usually develops as a result of the production of a specific immunoglobulin M auto-antibody directed against the I/i and H antigens, precursors of the ABH and Lewis blood group substances, on red blood cells. Autoimmune and lymphoproliferative disorders, Mycoplasma pneumoniae and other infections can be associated with the production of cold agglutinins. In its classic presentation with haemolytic anaemia and Raynaud's syndrome, cold agglutinin disease is usually idiopathic. Several factors play a role in determining the ability of a cold agglutinin to induce a haemolytic anaemia such as antibody concentration and temperature range, in particular the highest temperature at which antibodies interact with red blood cells. CASE
PRESENTATION: A 48-year-old Caucasian man presented to our hospital with symptoms of extreme asthenia caused by severe anaemia. The transfusion of red blood cells (O Rh-positive), started as prescribed by the emergency guidelines in force without pre-transfusion tests, induced fatal haemolysis because of the presence of high levels of anti-H antibodies in his blood, that reacted with the large amount of H antigen in universal (0) red blood cells.
CONCLUSION: Emergency transfusion of universal red blood cells (0 Rh-positive or negative) is usually accepted by the international guidelines in force in emergency departments. In this report we describe a rare complication caused by the very high concentration in the recipient of cold agglutinins and the activation of the complement system, responsible for red blood cell lysis and consequent fatal cardiovascular shock. We conclude that emergency transfusion of universal red blood cells (0 Rh-positive or negative) may be dangerous and its risk should be assessed against the risk of delaying transfusion until the pre-transfusion tests are completed.

Entities:  

Year:  2010        PMID: 20691050      PMCID: PMC2923177          DOI: 10.1186/1752-1947-4-252

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  1 in total

Review 1.  The cold hemagglutinin disease.

Authors:  H Schubothe
Journal:  Semin Hematol       Date:  1966-01       Impact factor: 3.851

  1 in total
  7 in total

Review 1.  Cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.

Authors:  Ulrich Jäger; Shirley D'Sa; Christian Schörgenhofer; Johann Bartko; Ulla Derhaschnig; Christian Sillaber; Petra Jilma-Stohlawetz; Michael Fillitz; Thomas Schenk; Gary Patou; Sandip Panicker; Graham C Parry; James C Gilbert; Bernd Jilma
Journal:  Blood       Date:  2018-12-17       Impact factor: 22.113

3.  Warm Autoimmune Hemolytic Anemia with a Direct Antiglobulin Test Positive for C3 and Negative for IgG: A Case Study and Analytical Literature Review of Incidence and Severity.

Authors:  Amruth R Palla; Farhad Khimani; Michael D Craig
Journal:  Clin Med Insights Case Rep       Date:  2013-04-02

4.  Mycoplasma pneumonia with persistent lymphadenopathy and severe cold agglutinin haemolysis.

Authors:  Mit Shah; Sajid Khan; Kenneth Chan
Journal:  Respir Med Case Rep       Date:  2016-10-17

5.  Effect of cold agglutinins on red blood cell parameters in a trauma patient: a case report.

Authors:  Anita Topic; Lara Milevoj Kopcinovic; Ana Bronic; Marina Pavic
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

Review 6.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

7.  Coomb's negative cold agglutinin disease: A rare report of an incidentally detected case.

Authors:  K V Vinu Balraam; Adnan Masood; Nidhi Garg; Venkatesan Somasundaram
Journal:  Asian J Transfus Sci       Date:  2021-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.